NexusXp at SLAS2025

Thank you for joining Virscidian, Biosero, and Waters at our SLAS2025 NexusXp exhibit highlighting our work automating DeepCure's Drug Discovery Process

In collaboration with...

Discover the Power of Collaboration:

‍Virscidian, Waters, and Biosero at SLAS2025 NexusXP exhibit

Thank you for visiting our SLAS2025 NexusXp exhibit where we highlighted our collaboration in support of DeepCure Laboratories' mission of revolutionizing drug discovery.

We combined AI-driven design, advanced synthesis automation, and cutting-edge software tools to create a seamless workflow for DeepCure's molecular foundry. This innovative platform enables the automated synthesis, purification, and analysis of 5,000–10,000 lead-like compounds each month, accelerating the drug discovery process.